These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 215107)
1. A study of Epstein Barr virus receptor activity in cell free extracts of human lymphoblastoid cells. Ng MH; Lui SW; Chan KH Arch Virol; 1978; 58(3):221-33. PubMed ID: 215107 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells. Yajima Y; Nonoyama M J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594 [TBL] [Abstract][Full Text] [Related]
3. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
4. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D Intervirology; 1975; 5(6):319-34. PubMed ID: 181343 [TBL] [Abstract][Full Text] [Related]
5. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin. Shapiro IM; Luka J; Andersson-Anvret M; Klein G Intervirology; 1979; 12(1):19-25. PubMed ID: 227812 [TBL] [Abstract][Full Text] [Related]
6. Antigenic content of an in vitro cellular immunity reactive cell surface extract of Raji cells. Ng MH; Ng WS; Ho HC Arch Virol; 1978; 58(3):213-20. PubMed ID: 215106 [TBL] [Abstract][Full Text] [Related]
7. Functional association of class II antigens with cell surface binding of Epstein-Barr virus. Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696 [TBL] [Abstract][Full Text] [Related]
8. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV. Cho MS; Fresen KO; zur Hausen H Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006 [TBL] [Abstract][Full Text] [Related]
9. Activation of Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells with propionic acid and with culture fluids of propionic acid-producing anaerobes. Kishishita M; Yanase S; Ito Y Cancer Lett; 1982; 16(2):117-20. PubMed ID: 6290028 [TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye. Sairenji T; Hinuma Y Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005 [TBL] [Abstract][Full Text] [Related]
11. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line, Dalianis T; Klein G; Andersson B Int J Cancer; 1977 Apr; 19(4):460-7. PubMed ID: 191413 [TBL] [Abstract][Full Text] [Related]
12. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines. Boguszaková L; Hirsch I; Brichácek B; Vonka V J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308 [TBL] [Abstract][Full Text] [Related]
13. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment. Shapiro IM; Andersson-Anvret M; Klein G Intervirology; 1978; 10(2):94-101. PubMed ID: 209000 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen. Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934 [TBL] [Abstract][Full Text] [Related]
15. Effect of adenine arabinoside on Epstein-Barr virus in vitro. Coker-Vann M; Dolin R J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542 [TBL] [Abstract][Full Text] [Related]
16. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus. Traul KA; Stephens R; Gerber P; Peterson WD Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous interferon production and Epstein-barr virus antigen expression in two human lymphoid cell lines and their somatic cell hybrids. Lidin B; Adams A Intervirology; 1975; 5(3-4):205-15. PubMed ID: 172473 [TBL] [Abstract][Full Text] [Related]
18. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus. Fujiwara S; Takada K; Yano S; Osato T Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870 [TBL] [Abstract][Full Text] [Related]
19. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Clements GB; Klein G; Povey S Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210 [TBL] [Abstract][Full Text] [Related]
20. Search for inhibitors against herpes simplex virus type-I in cell extracts derived from human lymphoblastoid cell lines. Lin KH Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Jun; 10(1-2):14-20. PubMed ID: 196817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]